Horizon Technology Finance, together with Monroe Capital, closed an initial $40 million senior credit facility for Ossio with an additional $10 million available to support future growth.
“We are thrilled to partner with Horizon Technology Finance and Monroe Capital on this growth capital investment. We look forward to executing on our strategy to expand our orthopedic fixation technology globally,” Brian Verrier, CEO of Ossio, said. “This partnership combines deep healthcare technology expertise with growth capital. Financing from the Horizon and Monroe platform provides the resources needed to accelerate expansion while preserving the company’s mission of transforming the orthopedic experience for patients.”
Paul Seitz, chief investment officer of Horizon, added, “We are excited to partner with Brian and the Ossio team as they broaden their global impact in orthopedic medical technology. This investment reflects Horizon’s commitment to supporting innovative, venture growth companies through strategic financing. Ossio marks another Horizon investment within the Israeli technology ecosystem.”
Mark Solovy, managing director and co-head, technology finance group at Monroe Capital, concluded, “Monroe continues to see exceptional innovation emerging from the Israeli life sciences sector, and Ossio stands out as a leading force in orthopedic and regenerative technology. Its disruptive, metal-free bone regeneration solutions align directly with our technology finance vertical, and we are proud to support Brian and his team as they globally scale Ossio’s impact.”
